Pierre-François Berne

1PUBLICATIONS
3CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Oct 13, 2020
Preclinical Activity of SAR408701: A Novel Anti-CEACAM5-maytansinoid Antibody-drug Conjugate for the Treatment of CEACAM5-positive Epithelial Tumors.

Stéphanie Decary, Pierre-François Berne, Céline Nicolazzi

Pageof 1

Frequent Collaborators

1 joint publications

Anne-Marie Lefebvre

1 joint publications

Catherine Prades

1 joint publications

Claire Brillac